177 related articles for article (PubMed ID: 24365145)
21. Enhanced Vector Design for Cancer Gene Therapy with Hierarchical Enhancement of Therapeutic Transgene Expression.
Kostina MB; Sass AV; Stukacheva EA; Korobko IV; Sverdlov ED
Hum Gene Ther Methods; 2017 Oct; 28(5):247-254. PubMed ID: 28446024
[TBL] [Abstract][Full Text] [Related]
22. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
[TBL] [Abstract][Full Text] [Related]
23. Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.
Pijlman GP; Suhrbier A; Khromykh AA
Expert Opin Biol Ther; 2006 Feb; 6(2):135-45. PubMed ID: 16436039
[TBL] [Abstract][Full Text] [Related]
24. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.
Luis A
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003492
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic applications of the ΦC31 integrase system.
Chavez CL; Calos MP
Curr Gene Ther; 2011 Oct; 11(5):375-81. PubMed ID: 21888619
[TBL] [Abstract][Full Text] [Related]
26. Non-viral amplification systems for gene transfer: vectors based on alphaviruses.
Smerdou C; Liljeström P
Curr Opin Mol Ther; 1999 Apr; 1(2):244-51. PubMed ID: 11715947
[TBL] [Abstract][Full Text] [Related]
27. Biopolymers augment viral vectors based gene delivery.
Balakrishnan B; David E
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502562
[TBL] [Abstract][Full Text] [Related]
28. Integrase-defective lentiviral vectors: progress and applications.
Banasik MB; McCray PB
Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
[TBL] [Abstract][Full Text] [Related]
29. Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon.
Vasilevska J; Skrastina D; Spunde K; Garoff H; Kozlovska T; Zajakina A
Cancer Gene Ther; 2012 Aug; 19(8):579-87. PubMed ID: 22722377
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic analysis of herpesviruses and their potential use as vectors for gene therapy applications.
Cotter MA; Robertson ES
Curr Opin Mol Ther; 1999 Oct; 1(5):633-44. PubMed ID: 11249670
[TBL] [Abstract][Full Text] [Related]
31. Targeted foreign gene expression in spinal cord neurons using poliovirus replicons.
Bledsoe AW; Gillespie GY; Morrow CD
J Neurovirol; 2000 Apr; 6(2):95-105. PubMed ID: 10822323
[TBL] [Abstract][Full Text] [Related]
32. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints.
Keravala A; Portlock JL; Nash JA; Vitrant DG; Robbins PD; Calos MP
J Gene Med; 2006 Aug; 8(8):1008-17. PubMed ID: 16779871
[TBL] [Abstract][Full Text] [Related]
33. Invasive drug delivery.
Blömer U; Ganser A; Scherr M
Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
[TBL] [Abstract][Full Text] [Related]
34. Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.
Piver E; Collin C; Renault N; Bru T; Pagès JC
J Virol; 2006 Oct; 80(19):9889-95. PubMed ID: 16973593
[TBL] [Abstract][Full Text] [Related]
35. Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector.
Liu Q; Perez CF; Wang Y
J Virol; 2006 Feb; 80(4):1672-9. PubMed ID: 16439524
[TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.
Leitner WW; Ying H; Driver DA; Dubensky TW; Restifo NP
Cancer Res; 2000 Jan; 60(1):51-5. PubMed ID: 10646851
[TBL] [Abstract][Full Text] [Related]
38. A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications.
Voigtlander R; Haase R; Mück-Hausl M; Zhang W; Boehme P; Lipps HJ; Schulz E; Baiker A; Ehrhardt A
Mol Ther Nucleic Acids; 2013 Apr; 2(4):e83. PubMed ID: 23549553
[TBL] [Abstract][Full Text] [Related]
39. Alphavirus DNA and particle replicons for vaccines and gene therapy.
Polo JM; Gardner JP; Ji Y; Belli BA; Driver DA; Sherrill S; Perri S; Liu MA; Dubensky TW
Dev Biol (Basel); 2000; 104():181-5. PubMed ID: 11713818
[TBL] [Abstract][Full Text] [Related]
40. Novel integrase-defective lentiviral episomal vectors for gene transfer.
Vargas J; Gusella GL; Najfeld V; Klotman ME; Cara A
Hum Gene Ther; 2004 Apr; 15(4):361-72. PubMed ID: 15053861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
